€188,028
▲ Purchases (20 ops.)
Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Skycrest Holdings, LLC. Officer active across 2 companies, notably Organicell Regenerative Medicine, Inc.. Cumulatively, 21 filings have been published. Split: 20 buys · 0 sell. Total volume traded: €188k. History available since 26 June 2023. The latest transaction was disclosed on 21 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations 21 total
1,000 shares @ US$2.10 1.1% of flow Common Stock SEC:0001829126-25-003927:0
Ideal exit: 15 Feb 2026 (T+270) 5,000 shares @ US$2.75 7.0% of flow Common Stock SEC:0001829126-25-003582:0
Ideal exit: 2 Feb 2026 (T+270) 5,000 shares @ US$2.81 7.1% of flow Common Stock SEC:0001829126-25-003489:0
Ideal exit: 2 Feb 2026 (T+270) 30,500 shares @ US$2.88 44.2% of flow Common Stock SEC:0001829126-25-003456:0
Ideal exit: 30 Jan 2026 (T+270) 949 shares @ US$2.10 1.0% of flow Common Stock SEC:0001829126-25-003280:0
Ideal exit: 25 Jan 2026 (T+270) 1,001 shares @ US$2.22 1.1% of flow Common Stock SEC:0001829126-25-003182:0
Ideal exit: 23 Jan 2026 (T+270) 175 shares @ US$2.05 0.2% of flow Common Stock SEC:0001829126-25-002958:0
Ideal exit: 18 Jan 2026 (T+270) 36 shares @ US$2.05 0.0% of flow Common Stock SEC:0001829126-25-002871:0
Ideal exit: 16 Jan 2026 (T+270) 2,400 shares @ US$1.90 2.3% of flow Common Stock SEC:0001829126-25-002683:0
Ideal exit: 6 Jan 2026 (T+270) 4,000 shares @ US$2.55 5.3% of flow Common Stock SEC:0001829126-25-002429:0
Ideal exit: 29 Dec 2025 (T+270) 5,000 shares @ US$3.00 8.2% of flow Common Stock SEC:0001829126-25-001162:0
Ideal exit: 17 Nov 2025 (T+270) 3,000 shares @ US$3.22 5.3% of flow Common Stock SEC:0001829126-25-000937:0
Ideal exit: 8 Nov 2025 (T+270) 520 shares @ US$2.65 0.8% of flow Common Stock SEC:0001829126-25-000728:0
Ideal exit: 31 Oct 2025 (T+270) 50 shares 0Series C Preferred SEC:0001829126-24-008637:0
266 shares @ US$3.02 0.4% of flow Common Stock SEC:0001829126-24-008285:0
Ideal exit: 7 Sept 2025 (T+270) 500 shares @ US$2.95 0.8% of flow Common Stock SEC:0001829126-24-007784:0
Ideal exit: 17 Aug 2025 (T+270) 10,000 shares @ US$2.59 14.0% of flow Common Stock SEC:0001829126-24-007713:0
Ideal exit: 15 Aug 2025 (T+270) 1,000 shares @ US$2.20 1.1% of flow Common Stock SEC:0001829126-24-006080:0
Ideal exit: 27 May 2025 (T+270) 320,710 shares @ US$0.009 21.1% of flow Common Stock SEC:0001829126-23-004623:0
Ideal exit: 2 Apr 2024 (T+270) 400,000 shares @ US$0.009 26.3% of flow Common Stock SEC:0001829126-23-004522:0
Ideal exit: 24 Mar 2024 (T+270) 800,000 shares @ US$0.009 52.6% of flow Common Stock SEC:0001829126-23-004454:0
Ideal exit: 22 Mar 2024 (T+270)